Intellectual Property - January 14, 2021
Follicum receives European patent
Follicum has announced that the European Patent Office (EPO) has approved a patent which refers to the company’s novel peptides that are being developed to treat diabetes. The approval follows the previous provisional approval by the EPO announced on March 20, 2020. The approval provides protection for the company’s peptides and their use to treat […]
Intellectual Property - October 14, 2020
Follicum obtains US patent
Follicum has announced that the patent which previously received a Notice of Allowance from the US Patent and Trademark Office has now also been formally approved by the authority. The patent is called “Peptides for Treatment of Diabetes” and the patent will be valid until 2038. The patent covers peptides from the company’s two peptide […]
Clinical Trials - August 24, 2020
More than 50% of patients enrolled in Follicum trial
Follicum has announced that more than 50% of the patients have been recruited in the ongoing, clinical phase IIa study with FOL-005. The study involves 200 male patients with hair loss who are treated daily for four months with a newly developed topical formulation of FOL-005 or placebo. The study is being conducted at the Clinical […]
Intellectual Property - June 26, 2020
Follicum receives Notice of Allowance from the US Patent Office
Follicum has received information that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance of the US patent application. The patent application covers the company’s peptides and their use for treatment of diabetes and diabetes-associated complications. The application is directed to new peptides from the company’s two peptide classes, and […]
Clinical Trials - June 4, 2020
Follicum re-starts phase II study
Follicum has announced that the clinical Phase IIa study with a cream-like formulation of FOL-005 will re-start, following a pause due to the Covid-19 pandemic. To increase the recruitment rate, a third study centre has been contracted. The study comprises approximately 200 male patients with hair loss who are treated daily for four months with the […]
Intellectual Property - May 13, 2020
Follicum files international patent application
Follicum files international patent application conferring extended protection for the topical formulation of FOL-005 and other peptides. The patent application is based on new experimental data that supports the use of the formulation for peptides other than FOL-005. The formulation of FOL-005 intended for topical application on the skin has been shown to provide good […]
